BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34763367)

  • 1. Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation.
    Ahmed S; Zhao Q; Hanel W; Qazilbash MH; Patel K; Narra R; Kansagra A; Iqbal M; Awan FT; Christian B; Jaglowski SM; Kharfan-Dabaja MA; Hamadani M; Epperla N
    Hematol Oncol; 2022 Feb; 40(1):48-56. PubMed ID: 34763367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation.
    Epperla N; Badar T; Szabo A; Vaughn J; Borson S; Saini NY; Patel RD; Shah NN; Hamadani M; Ahmed S; Cashen AF; Fenske TS
    Blood Adv; 2019 Jun; 3(11):1661-1669. PubMed ID: 31167818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: A Systematic Review and Meta-analysis.
    Parrondo RD; Reljic T; Iqbal M; Ayala E; Tun HW; Kharfan-Dabaja MA; Kumar A; Murthy HS
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e694-e711. PubMed ID: 32616401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
    Smith SM; Godfrey J; Ahn KW; DiGilio A; Ahmed S; Agrawal V; Bachanova V; Bacher U; Bashey A; Bolaños-Meade J; Cairo M; Chen A; Chhabra S; Copelan E; Dahi PB; Aljurf M; Farooq U; Ganguly S; Hertzberg M; Holmberg L; Inwards D; Kanate AS; Karmali R; Kenkre VP; Kharfan-Dabaja MA; Klein A; Lazarus HM; Mei M; Mussetti A; Nishihori T; Ramakrishnan Geethakumari P; Saad A; Savani BN; Schouten HC; Shah N; Urbano-Ispizua A; Vij R; Vose J; Sureda A; Hamadani M
    Cancer; 2018 Jun; 124(12):2541-2551. PubMed ID: 29645093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
    Kambhampati S; Hunter B; Varnavski A; Fakhri B; Kaplan L; Ai WZ; Pampaloni M; Huang CY; Martin T; Damon L; Andreadis CB
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):246-256.e2. PubMed ID: 33288485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT.
    Badar T; Epperla N; Szabo A; Borson S; Vaughn J; George G; Saini N; Shah AR; Patel RD; Ahmed S; Shah NN; Cashen AF; Hamadani M; Fenske TS
    Blood Adv; 2020 Jan; 4(1):47-54. PubMed ID: 31899797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma.
    Cornell RF; Bachanova V; D'Souza A; Woo-Ahn K; Martens M; Huang J; Al-Homsi AS; Chhabra S; Copelan E; Diaz MA; Freytes CO; Gale RP; Ganguly S; Hamadani M; Hildebrandt G; Kamble RT; Kharfan-Dabaja M; Kindwall-Keller T; Lazarus HM; Marks DI; Nishihori T; Olsson RF; Saad A; Usmani S; Vesole DH; Yared J; Mark T; Nieto Y; Hari P
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):60-66. PubMed ID: 27789362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
    Klyuchnikov E; Bacher U; Kröger NM; Hari PN; Ahn KW; Carreras J; Bachanova V; Bashey A; Cohen JB; D'Souza A; Freytes CO; Gale RP; Ganguly S; Hertzberg MS; Holmberg LA; Kharfan-Dabaja MA; Klein A; Ku GH; Laport GG; Lazarus HM; Miller AM; Mussetti A; Olsson RF; Slavin S; Usmani SZ; Vij R; Wood WA; Maloney DG; Sureda AM; Smith SM; Hamadani M
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2091-2099. PubMed ID: 26253007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study.
    Shargian L; Amit O; Bernstine H; Gurion R; Gafter-Gvili A; Rozovski U; Pasvolsky O; Perets G; Horowitz NA; Halloun J; Perry C; Avivi I; Raanani P; Yeshurun M; Ram R
    Eur J Haematol; 2023 Feb; 110(2):149-156. PubMed ID: 36251268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
    Anagnostopoulos A; Hari PN; Pérez WS; Ballen K; Bashey A; Bredeson CN; Freytes CO; Gale RP; Gertz MA; Gibson J; Goldschmidt H; Lazarus HM; McCarthy PL; Reece DE; Vesole DH; Giralt SA
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):845-54. PubMed ID: 16864055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic cell transplantation for Waldenström macroglobulinemia.
    Bachanova V; Burns LJ
    Bone Marrow Transplant; 2012 Mar; 47(3):330-6. PubMed ID: 21572463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of stem cell transplantation for Waldenström's macroglobulinemia: analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group.
    Sakurai M; Mori T; Uchiyama H; Ago H; Iwato K; Eto T; Iwasaki H; Kawata T; Takamatsu H; Yamasaki S; Takanashi M; Ichinohe T; Atsuta Y; Suzuki R
    Ann Hematol; 2020 Jul; 99(7):1635-1642. PubMed ID: 32424672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience.
    Pasvolsky O; Gaballa MR; Milton DR; Masood A; Sami SS; Tanner MR; Bashir Q; Srour S; Saini N; Ramdial J; Nieto Y; Tang G; Lin P; Lee HC; Patel KK; Kebriaei P; Thomas SK; Weber DM; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH
    Transplant Cell Ther; 2023 Apr; 29(4):260.e1-260.e6. PubMed ID: 36646323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation.
    Pemmaraju N; Tanaka MF; Ravandi F; Lin H; Baladandayuthapani V; Rondon G; Giralt SA; Chen J; Pierce S; Cortes J; Kantarjian H; Champlin RE; De Lima M; Qazilbash MH
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):485-92. PubMed ID: 23769669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
    Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era?
    Shah NN; Ahn KW; Litovich C; He Y; Sauter C; Fenske TS; Hamadani M
    Blood; 2021 Mar; 137(10):1416-1423. PubMed ID: 33120429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysis.
    Epperla N; Reljic T; Chowdhury SM; Ferreri AJM; Kumar A; Hamadani M
    Hematol Oncol; 2023 Feb; 41(1):88-96. PubMed ID: 36192141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
    Shadman M; Pasquini M; Ahn KW; Chen Y; Turtle CJ; Hematti P; Cohen JB; Khimani F; Ganguly S; Merryman RW; Yared JA; Locke FL; Ahmed N; Munshi PN; Beitinjaneh A; Reagan PM; Herrera AF; Sauter CS; Kharfan-Dabaja MA; Hamadani M
    Blood; 2022 Mar; 139(9):1330-1339. PubMed ID: 34570879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.
    Drozd-Sokołowska J; Gras L; Zinger N; Snowden JA; Arat M; Basak G; Pouli A; Crawley C; Wilson KMO; Tilly H; Byrne J; Bulabois CE; Passweg J; Ozkurt ZN; Schroyens W; Lioure B; Colorado Araujo M; Poiré X; Van Gorkom G; Gurman G; de Wreede LC; Hayden PJ; Beksac M; Schönland SO; Yakoub-Agha I
    Bone Marrow Transplant; 2022 Apr; 57(4):633-640. PubMed ID: 35169284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.